cgp 20712a has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dubbin, PN; Dusting, GJ; Macdonald, PS | 1 |
| Pfaffendorf, M; van Zwieten, PA; Winkler Prins, EA; Zwaveling, J | 1 |
| Brahmadevara, N; MacDonald, A; Shaw, AM | 1 |
3 other study(ies) available for cgp 20712a and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
| Article | Year |
|---|---|
Beta-adrenoceptors on endothelial cells do not influence release of relaxing factor in dog coronary arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Biological Products; Bradykinin; Coronary Vessels; Dogs; Endothelium, Vascular; Imidazoles; In Vitro Techniques; Isoproterenol; Nitric Oxide; Propanolamines; Prostaglandin Endoperoxides, Synthetic; Receptors, Adrenergic, beta; Vasodilation | 1987 |
The influence of hyperthyroidism on beta-adrenoceptor-mediated relaxation of isolated small mesenteric arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Colforsin; Dose-Response Relationship, Drug; Hyperthyroidism; Imidazoles; Isoproterenol; Male; Mesenteric Arteries; Methoxamine; Muscle Contraction; Muscle Relaxation; Propanolamines; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Wistar; Thromboxane A2; Thyroxine; Vascular Resistance; Vasoconstrictor Agents | 1996 |
ALpha1-adrenoceptor antagonist properties of CGP 12177A and other beta-adrenoceptor ligands: evidence against beta(3)- or atypical beta-adrenoceptors in rat aorta.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Antagonists; Alprenolol; Animals; Aorta, Thoracic; Binding Sites; Bupranolol; Cell Membrane; Cerebral Cortex; Dose-Response Relationship, Drug; Ethanolamines; Imidazoles; Male; Muscle, Smooth, Vascular; Phenylephrine; Pindolol; Prazosin; Propanolamines; Propranolol; Radioligand Assay; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta-3; Tritium; United Kingdom; Vasoconstriction | 2004 |